Next Article in Journal
The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS—A Long-Term Follow-Up Study
Next Article in Special Issue
Correlation of Plasma Amino Acid and Anthropometric Profiles with Brown Adipose Tissue Density in Humans
Previous Article in Journal
A Systematic Review and Meta-Analysis of the Implementation of High-Performance Cardiopulmonary Resuscitation on Out-of-Hospital Cardiac Arrest Outcomes
Previous Article in Special Issue
Quality Assessment of Untargeted Analytical Data in a Large-Scale Metabolomic Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 10
Issue 10
10.3390/jcm10102100
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multi-Omics Analysis of Anti-Inflammatory Action of Alkaline Extract of the Leaves of Sasa sp.

by
Hiroshi Sakagami
1,*,
Sachie Nakatani
2,
Ayame Enomoto
3,
Sana Ota
3,
Miku Kaneko
3,
Masahiro Sugimoto
3,4,
Misaki Horiuchi
5,
Kazuki Toeda
5 and
Takaaki Oizumi
5
1
Meikai University Research Institute of Odontology (M-RIO), Meikai University School of Dentistry, 1-1 Keyakidai, Sakado, Saitama 350-0283, Japan
2
Graduate School of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan
3
Institute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan
4
Research and Development Center for Minimally Invasive Therapies, Institute of Medical Science, Tokyo Medical University, Shinjuku, Tokyo 160-0022, Japan
5
Daiwa Biological Research Institute Co., Ltd., Sakado 3-2-1, Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(10), 2100; https://doi.org/10.3390/jcm10102100
Received: 10 March 2021 / Revised: 29 April 2021 / Accepted: 11 May 2021 / Published: 13 May 2021
(This article belongs to the Special Issue Metabolomic Analysis in Health and Disease)
Browse Figures
Review Reports Versions Notes

Abstract

:
Efficient utilization of alkaline extracts of several plants for the treatment of oral diseases has been reported. To investigate the mechanism of anti-inflammatory activity of alkaline extract of the leaves of Sasa sp. (SE), multi-omics analysis using metabolomics and DNA array was performed. Human gingival fibroblasts (HGFs) were treated for IL-1β to induce inflammation (detected by PGE2 production in culture medium) in the presence or absence of SE. Both IL-1β and SE showed slight hormetic growth stimulation against HGF. SE inhibited PGE2 production dose- and time-dependently. Its inhibitory action was more pronounced by first treating the cells with SE, rather than with IL-1β. At 3 h after IL-1β treatment, 18 amino acids (except cysteine and glutamic acid), total glutathione (GSH, GSSG, Cys-GSH disulfide), Met-sulfoxide, 5-oxoproline, and SAM declined, whereas DNA expressions of AKT, CASP3, and CXCL3 were elevated. These changes were reversed by simultaneous treatment with SE. The present study suggests that the anti-inflammatory action of SE is mediated via various metabolic pathways for cell survival, apoptosis, and leukocyte recruitment.

1. Introduction

Alkaline extracts of many plants such as licorice root [1], green tea leaf, oolong tea leaf and orange flower [2] have been reported to show much higher anti-HIV activity than water extracts of counterpart plants, possibly due to higher amount of lignin–carbohydrate complexes, which are more efficiently extracted by alkaline solution than hot water. In fact, the anti-HIV activity of the aklaine extract of bamoo leaf declined by removal of the lignin–carbohydrate complex [3]. Although many papers have reported the utilization of alkaline extract for the treatment of oral disease, mechanistic analysis of biological actions such as bone regeneration and anti-inflammation [4], periodontal inflammation and alveolar bone loss [5], anti-oral bacterial activity [6], and alleviation of oral lichenoid dysplasia [7] by alkaline extract has been limited.
Alkaline extract of the leaves of Sasa sp. (SE) showed potent anti-viral activity, and its chemotherapeutic index (safety margin) (SI) (determined by the ratio of CC50 (50% cytotoxic concentration in uninfected cells)/EC50 (50% protective concentration of HIV-infected cells) was 86, comparable with that of lignin–carbohydrate complex (SI = 12~311 (mean: 76) (n = 6) and higher than those of hundreds of chemically defined tannins (SI = 1.1~7.3) (n = 75) and flavonoids (SI = 1.5~24) (n = 114) [8]. Furthermore, SE showed potent anti-inflammation activity (assessed by inhibition of PGE2 production and COX-2 protein expression [8] and interleukin (IL)-8 production [6]) against an IL-1β-induced inflammation model with human gingival fibroblasts (HGFs) [9]. Although many researchers have isolated and determined the chemical structures of thousands of low molecular weight compounds, such as tannins and flavonoids, from the natural kingdom, the yield of purified materials is in the milligram order. In contrast, SE can be obtained in the gram order, and is thus suitable for manufacturing over-the-counter (OTC) drugs such as oral rinse and toothpaste [10]. Upon high-performance liquid chromatography (Develosil RPAQUEOUS (C-30), SE was eluted as a single peak at the retention time of 22.175 min, suggesting that SE is present in a multi-biological complex [11]. Among nearly 30 papers on the anti-inflammatory activity of bamboo extracts, only one paper other than our papers used the alkaline extract [12]. All of them focused on the later stage of inflammation, and none of them considered the dental application.
To clarify the action point of SE, optimal condition for induction of inflammation by IL-1β was first investigated. Since inflammation starts as early as 3 h after IL-1β stimulation, the intracellular metabolites and genes that are upregulaed by IL-1β and then downregulated by SE at the earlier stage of inflammation of HGF were identified by metabolomics and DNA microarray analyses, respectively. The earlier stage of inflammation was chosen for the analysis, since at the later stage many different signals may exert non-specific biological actions.

2. Experimental Section

2.1. Materials

The following chemicals and reagents were purchased from the indicated companies: Dulbecco’s modified Eagle’s medium (DMEM) from GIBCO BRL (Grand Island, NY, USA); fetal bovine serum (FBS) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) from Sigma-Aldrich Inc. (St. Louis, MO, USA); dimethyl sulfoxide (DMSO) from Wako Pure Chem. Ind. (Osaka, Japan); 96-microwell plate from TPP (Techno Plastic Products AG, Trasadingen, Switzerland); a 10 cm dish from Becton Dickinson Labware (Franklin Lakes, NJ, USA); interleukin (IL)-1β, R&D systems (Minneapolis, MN, USA).
SE was prepared by iron ion substitution, alkaline extraction, and neutralization/desalting. Lyophilization and measurement of the dry weight of SE showed that it contained 58.2 ± 0.96 mg solid materials/mL [10,13].

2.2. Cell Culture

Human gingival fibroblasts (HGFs), human periodontal ligament fibroblasts (HPLFs), and human pulp cells (HPCs) were obtained from the first premolar extracted tooth in the lower jaw and periodontal tissues of a twelve-year-old girl, according to the guideline of the Institutional Board of Meikai University Ethics Committee (No. A0808) after obtaining informed consent from the patients [14]. For the present study, cells at the population doubling level (PDL) of 10–15 were cultured in DMEM supplemented with 10% heat-inactivated FBS, 100 units/mL penicillin G, and 100 μg/mL streptomycin sulfate under humidified 5% CO2 atmosphere.

2.3. Assay for Cytotoxic Activity

Cells were seeded at 2 × 103 cells/0.1 mL in the inner 60 wells of a 96-microwell plate (Falcon Becton Dickinson, Franklin Lakes, NJ, USA). The surrounding 36 exterior wells were filled with 0.1 mL of sterilized water to minimize the evaporation of water from the culture medium. After 48 h, the medium was removed by suction with an aspirator, and replaced with 0.1 mL of fresh medium containing different concentrations of the sample. Cells were incubated for the indicated times, and the relative viable cell number was then determined by the MTT method [9]. Briefly, the treated cells were incubated for another 2 h in a fresh culture medium containing 0.2 mg/mL MTT. Cells were then lysed with 0.1 mL of DMSO and the absorbance at 560 nm of the cell lysate was determined using a microplate reader (Infinite F 50 R, TECAN, Kawasaki, Japan).

2.4. Assay for Pro-Inflammatory Substances

The concentration of PGE2 released into the culture medium was determined by enzyme immunoassay (EIA) (Cayman Chemical Co., Ann Arbor, MI, USA).

2.5. Processing for Metabolomic Analysis

Near confluent cells in a 10 cm dish were treated for 3 h with 0 (control), IL-1β (3 ng/mL), SE (1%) or IL-1β (3 ng/mL) + SE (1%). Aliquots of the cells were trypsinized and the viable cell number was counted with a hemocytometer after staining with trypan blue. The remaining cells were washed twice with 5 mL of ice-cold 5% D-mannitol and then immersed for 10 min in 1 mL of methanol containing internal standards (25 μM each of methionine sulfone, 2-[N-morpholino]-ethanesulfonic acid and D-camphor-10-sulfonic acid). The methanol extract (supernatant) was collected. The aqueous layer was filtered to remove large molecules by centrifugation through a 5 kDa cut-off filter (Millipore, Billerica, MA, USA) at 9100× g for 2.5 h at 4 °C. The 320 μL of the filtrate was concentrated by centrifugation and dissolved in 50 μL of Milli-Q water containing reference compounds (200 μM each of 3-aminopyrrolidine and trimesate) immediately before capillary electrophoresis-time-of-flight-mass spectrometry (CE-TOF-MS) analysis. The parameters of the measurement instrument and data processing have already been described. The concentrations of intracellular metabolites were expressed as amol/cell [15,16].

2.6. DNA Microarray Processing

Total RNA was extracted from the cells using RNA iso plus reagent (Takara Bio, Tokyo, Japan) according to the manufacturer’s instructions. RNA quantity and quality were determined using the Nano Drop 2000 (Thermo Fisher Scientific K. K., Tokyo, Japan) and RNA 6000 Nano Assay kit on an Agilent 2100 BioAnalyzer (Agilent Technologies Japan, Ltd., Tokyo, Japan), as recommended. RNA samples were used for cRNA target preparation only when the ratio A260:A280 was 1.8–2.1 and the RNA Integrity Number (RIN) value was >7.8.
DNA microarray was performed on the duplicated samples of 4 treatment groups. The Sure-Print G3 Human GE 8 × 60 K Ver. 3.0 array kit (Agilent Technologies Japan, Tokyo, Japan) was used for cRNA target preparation and DNA microarray hybridization detection. Following an assessment of total RNA concentration and quality, 200 ng of the RNA sample from each cell was used for microarray experiments. RNA Spike-In one-color kit (Agilent Technologies Japan, Tokyo, Japan) was used to efficiently monitor their microarray workflow for accuracy. Synthesis of first-strand and second-strand cDNA was performed with T7 promoter primer. Cy3-labeled cRNA was amplified with T7 RNA polymerase Blend and cyanine3-CTP at 40 °C for 2 h and purified using the RNAeasy kit (Qiagen, K.K., Tokyo, Japan). The resulting purified Cy3-labeled cRNA was assessed for concentration, purity, and quantity. In total, 600 ng of Cy3-labeled cRNA was fragmented at 60 °C for 30 min with the fragmentation buffer of Gene Expression Hybridization Kit (Agilent, Tokyo, Japan). The fragmented cRNA with 2× GE Hybridization buffer HI-RPM was loaded into the array slide and hybridized at 65 °C for 17 h. The microarrays were washed with Gene Expression Wash Buffer 1 (Agilent, Tokyo, Japan) at room temperature for 1 min and with Wash Buffer 2 (Agilent, Tokyo, Japan) at 37 °C for 1 min. After drying, the microarrays were immediately scanned with a DNA Microarray Scanner (Agilent, Tokyo, Japan) at 3 μm.
Initial data analysis was performed using Feature Extraction software (Agilent, Tokyo, Japan) to exclude outlier pixels, accurately determine feature intensities and ratios, and calculate statistical confidences. Raw intensities were normalized using a 75th percentile global normalization and law signal cut-off for each spot before further analysis of the quantified data using Subio Platform Basic Plug-in (Subio Inc., Aichi, Japan).
Further information concerning gene function, functional annotation clustering, and the biological and molecular function of each gene analyzed was obtained with Subio Platform Advanced Plug-in (Subio Inc., Aichi, Japan) and KeyMolnet Lite (IMMD Inc., Tokyo, Japan) software.

2.7. Statistical Analysis

Statistical analyses were performed using the Origin Pro 2018 software (Origin Lab Corporation, MA, USA). Experimental data are presented as the mean ± standard deviation (SD) of triplicate determinations. The statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc test for multiple comparisons. A value of p < 0.05 was considered to indicate statistically significant differences.

3. Results

3.1. Pretreatment, Rather Than Post-Treatment, with SE More Efficiently Inhibited IL-1β-Stimulated PGE2 Production in HGF.t

3.1.1. Optimal Conditions for Induction of Inflammation by IL-1β

We first set up the optimal condition for measuring the anti-inflammatory action of SE (Figure 1). Interleukin (IL)-1β induced an approximately 100-fold increase in PGE2 production in human gingival fibroblasts (HGFs) and human periodontal fibroblasts (HPLFs), but not in human pulp cells (HPCs) (A). The optimal concentration of IL-1β was 3.1~12.5 (ng/mL). Since higher PGE2 production was observed in HGF than HPLF, we used HGF in the following experiments. The production of PGE2 was observed 3 h after IL-1β (3 ng/mL) treatment and increased up to 48 h (B). The addition of SE up to 10% did not interfere with the actual determination of PGE2 with ELISA (C). Unless otherwise stated, cells were treated for 48 h with IL-1β (3 ng/mL).

3.1.2. Inhibition of IL-1β-Induced Inflammation by SE

SE dose-dependently reduced the IL-1β-induced PGE2 production. In the presence of 1 or 2% SE, PGE2 production was reduced to 9.1 and 3.0% of control, respectively. The inhibitory effect of SE was more pronounced when SE was added before IL-1β addition (D). When HGF cells were preincubated for longer times with IL-1β before the addition of SE, the inhibitory effect of SE was progressively reduced (E). However, approximately 25% of PGE2 production remained even if HGF cells were incubated for 5 h with 2% SE (E). This suggests that some parts of SE may bind to IL-1β extracellularly and block its binding to a cellular receptor and then inhibit the signal transduction of IL-1β.

3.1.3. Mild Growth Stimulation Effect of IL-1β and SE

A careful inspection revealed that both IL-1β and SE slightly stimulated the growth of HGF (A, D). Reproduced results were obtained by repeated experiments. This is consistent with our finding that SE stimulates the growth of differentiated rat PC12 neuronal cells in a serum-free medium [17].

3.2. Metabolome Analysis

A total of 153 metabolites were detected. p-Coumaric acid, one of the precursors of the lignin–carbohydrate complex (LCC) [18,19], was detected in both cells and medium, indicating that SE contains LCC as major anti-viral and anti-inflammatory substances. There were many metabolites whose expressions were increased or decreased by IL1-β or by SE. Interestingly, when column 2 and column 3 were compared (Figure 2A), their patterns of ups and downs were found to not be overlapped with each other.
Treatment of HGF cells with IL-1β resulted in a 38% decline of a total of 18 amino acids (except cysteine and glutamic acid) (Table 1). Cysteine was not detected due to the degradation during sample preparation. Additionally, total glutathione (GSH, GSSG, and cysteine-glutathione disulfide), Met-sulfoxide, 5-oxoproline, and S-adenosylmethionine (SAM) declined. These changes were reversed by simultaneous treatment with SE. ATP utilization (assessed by the ratio of AMP/ATP and ADP/ATP) and GTP utilization (assessed by the ratio of GMP/GTP and GDP/GTP) were elevated by 60–88% and 35–44%, respectively, due to IL-1β and were reversed to near the control level by SE (Table 1).

3.3. DNA Array Analysis

The flow chart of DNA array analysis is shown in Figure 3. After removing inappropriate spots, 57,432 spots were selected. After normalization, the spots within the range of log 2 (2), compared with control, were removed, and the remaining 16,405 spots were subjected to DNA microarray analysis. Next, we extracted the genes whose expressions were enhanced more than twice by IL-1β and reduced to 1/2 by simultaneous addition by SE to obtain 366 genes. These genes were subjected to assay for the KEGG pathway.
Changes in the expression intensity of 16,405 genes are shown in Figure 4. There were many genes whose expressions were increased by IL1-β compared to the control, and there was a group of genes in which the increase by IL1-β was suppressed by SE + IL1-β (Figure 4).
IL1-β induced mRNA expression of 26 genes including tumor necrosis factor superfamily member 2 (TNFA) (21.439-fold), RAC serine/threonine-protein kinase (AKT) (22.32-fold), caspase 3 (CASP3) (21.027-fold). These expression levels were suppressed by adding SE at the same time. In particular, CASP3 was induced about twice as much as the control (21.072-fold) by adding IL1-β, but it was returned to the control level by adding SE at the same time (Table 2). On the other hand, chemokines such as CXC motif chemokine on the TNF pathway (CXCL3) were increased to a greater extent (28.826-fold), but their expression did not return to the control level. Highly expressed mRNAs are depicted in Figure 5, where magnitudes of amplification are indicated by the thickness of red circles.

4. Discussion

The present study demonstrated that SE inhibited the IL1-β-induced inflammation (PGE2 production and other inflammatory cytokines) [9], and the anti-inflammatory action of SE was partially inhibited when HGF cells were treated with SE after pretreatment with IL1-β (Figure 1). This suggests that one of the anti-inflammatory actions of SE may be mediated by the inhibition of IL1-β binding to its cellular receptor (IL1-βR) by masking the ligand or receptor. Since HGF expresses various cell surface receptors of various inflammatory cytokines upon stimulation [17], SE may non-specifically inhibit the ligand–receptor interactions of all cytokines. Further studies are necessary to test this possibility.
SE contains numerous components including the lignin–carbohydrate complex and its degradation products [13]. Such components bind with each other, producing the aggregated form [11]. At present, it is not clear which components or aggregate formations are responsible for the anti-inflammatory action of SE. The present metabolomic analysis demonstrated that (i) SE contains p-coumaric acid, one of the degradation products of lignin–carbohydrate complex, (ii) it was incorporated into the cells (332 atom/cell), and (iii) IL1-β treatment slightly increased its intracellular concentration (511 amol/cell) with the reduction in the extracellular concentration from 146 to 139 µM (Supplementary Table S4). This suggests the possibility that the anti-inflammatory activity of SE might be in part to p-CA. However, this possibility was eliminated by our finding that the anti-inflammatory activity of p-coumaric acid against HPLF (assessed by chemotherapeutic index CI (=CC50/IC50)) was much less than SE (chemotherapeutic index >3.1 vs. >96.3) (Supplementary Figure S1). We also found that the anti-inflammatory activity of other popular polyphenols such as curcumin, gallic acid, and ferulic acid was very low (CI = 0.94~2.9). On the other hand, Japanese traditional medicines (Kampo), such as Hangeshashinto [20,21] inhibited IL-1β-stimulated PGE2 production, to the comparable extent with that of SE (CI = 100). Endotoxin contamination of Hangeshashinto and SE was 8.7 [22] and <2 ng/g (under the detection limit, possibly due to the cleavage of the ester bond of LPS during alkaline extraction), respectively. These data indicate that the anti-inflammatory activity of SE is higher than popular low molecular weight polyphenols and comparable with that of Kampo medicines.
The present study demonstrated that IL1-β reduced approximately 40% of intracellular concentrations of amino acids, which was reversed to some extent by the addition of SE (Table 3). At present, the biological significance of this finding is not clear. Similarly, SE rescued the IL1-β-induced decline of total glutathione and Met-sulfoxide and 5-oxoproline to some extent. This is consistent with our previous finding that Met-sulfoxide and 5-oxoproline declined during the aggravation of IL1-β-induced HGF inflammation by TiO2 nanoparticles (Supplementary Figure S2A,B, cited from [15]). Since Met-sulfoxide [23,24,25] and 5-oxoproline [26,27,28] are well-known markers reflecting oxidative stress, SE might have induced the cells to fight against oxidative stress.
We have previously reported that SAM level step-wisely declined with aggravation of inflammation triggered by IL1-β then TiO2 nanoparticles (Supplementary Figure S2C). The present study showed that, during recovery from inflammation by SE, SAM returned to near the control level (Table 2). SAM is synthesized in a cyclic pathway (termed one-carbon metabolism) from methionine and ATP by methionine adenosyltransferase (EC 2.5.1.6). During inflammation, methionine and ATP levels decline, thus leading to the decline of SAM, which is a well-known methyl group transfer. Since methylation of DNA and histone is known to repress the expression of various genes, a poor supply of SAM may lead to the enhanced expression of pro-inflammatory cytokines [29]. Therefore, reversal of SAM by SE can be considered to be the trigger of anti-inflammatory action.
IL-1β is an important mediator of the inflammatory response and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The present DNA microarray analysis demonstrated the activation of four independent pathways by IL1-β, which were also reversed by SE: tumor necrosis factor superfamily member 2 (TNFA), RAC serine/threonine-protein kinase (AKT), and caspase 3 (CASP3) (Figure 5, Table 3). An increase in the ATP and GTP utilization favors the commitment of cells towards apoptosis since the elevation of cytosolic ATP level is a requisite to the apoptotic cell death process [30]. Several papers have reported the mild apoptosis induction (detected by annexin staining) of HGF by IL-1β [31]. IL-1β also induced mild growth stimulation of HGF by upregulation of NF-κB pathway members [32], supporting our data. IL-1β also increased matrix metalloproteinase (MMP) levels [33,34]. Simultaneous stimulation with transforming growth factor (TGF)-β1 or IL-1β induce weak apoptosis and then augment IL-8 and VEGF production [35]. Such weak apoptosis may induce proinflammatory cytokines and adherent molecules by HGF, leading to the exacerbation of periodontal disease.
IL-1β induces the activation of Akt by 473 serine phosphorylation, in a PI-3K-dependent manner, and the inhibition of Akt prevents IL-1β-mediated differential embryo-chondrocyte expressed gene 1 (DEC1) and HIF-1α induction in HGF. Although IL-1β induced the expression chemokine CXCL10 and attached factor ICAM-1, in synergy with oncostatin M [36], the inhibition of CXCL10 by SE was mild (Table 2). This suggests that chemokines may not be tightly involved in the anti-inflammatory action of SE.
We have previously shown that SE and lignin–carbohydrate, both extracted by alkaline solution, showed potent anti-viral activity. Their anti-viral potential [37,38,39,40,41,42,43] is two-fold higher than that of tannins and flavonoids [44,45,46]. Recently, SE instantly inactivated both HSV and HIV, and their chemotherapeutic index is much higher than povidone-iodine. This suggests the superiority of SE over povidone-iodine for mouth wash for preventing virus infection [10]. A combination of presently described anti-inflammatory activity and potent anti-viral activity may synergistically improve the oral environment.
In conclusion, the present study demonstrated, for the first time, that the anti-inflammatory action of SE is mediated via various metabolic pathways for cell survival, apoptosis, and leukocyte recruitment. Since SE showed potent anti-inflammatory activity, in addition to its potent anti-viral activity reported previously, the applicability of SE to oral inflammation and virally induced oral diseases was suggested.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/jcm10102100/s1, Figure S1: Anti-inflammatory activity of p-coumaric acid and other lower molecular polyphenols, Figure S2: Changes in the intracellular concentrations of methionine sulfoxide, 5-oxoproline and SAM after addition of IL-1β (3 ng/mL) and TiO2 nanoparticles in HGF. Table S1: Original data for Figure 2, Table S2: Original data with SD values for Table 1, Table S3: Original data for Table 2, Table S4: Intracellular and extracellular concentration of p-coumaric acid.

Author Contributions

Resources, M.H., K.T., and T.O.; methodology, S.N. and M.S.; formal analysis, A.E., S.O., and M.K.; data curation, M.S.; writing—original draft preparation, H.S.; writing—review and editing, M.S.; supervision, H.S.; funding acquisition, M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a JSPS KAKENHI (25463663), grants from Yamagata prefecture and Tsurruoka City, and Meikai University Miyata Research Fund B.

Institutional Review Board Statement

Ethical review and approval were waived for this study, since we have used only cultured cells that had been established in our laboratory eleven years ago under the guidance of intramural ethic board (No. A0808).

Informed Consent Statement

Not applicable, since we used only cultured cells.

Data Availability Statement

We have provided our previous data that support our present findings in the supplementary materials Figure S2.

Acknowledgments

The authors acknowledge the support from Meikai University and the Joint Research Fund of Meikai University; Daiwa Biological Co. Ltd. (H.S.). This work was supported by a Grant-in-Aid for Scientific Research to M.S. (No. 20B205) and the grants from Yamagata Prefecture and Tsuruoka City to M.S., S.O, A.E., and K.M.

Conflicts of Interest

M.H., K.T., and T.O. come from Daiwa Biological Research Institute Co., Ltd., Kanagawa, Japan. Corresponding authors (H.S.) received the financial support of research funds from Daiwa Biological Research Institute. The authors confirm that such financial supports have not influenced the outcome of the experimental data. The other authors declare no conflict of interest.

References

  1. Ohno, H.; Miyoshi, S.; Araho, D.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Tsuda, T.; Sunaga, K.; Amano, S.; Ohkoshi, E.; et al. Efficient utilization of licorice root by alkaline extraction. In Vivo 2014, 28, 785–794. [Google Scholar]
  2. Sakagami, H.; Ohkoshi, E.; Amano, S.; Satoh, K.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Sunaga, K.; Otsuki, T.; Ikeda, H.; et al. Efficient utilization of plant resources by alkaline extraction. Altern. Integr. Med. 2013, 2, 1–7. [Google Scholar]
  3. Sakagami, H.; Iwamoto, S.; Matsuta, T.; Satoh, K.; Shimada, C.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Morita, Y.; Ohkubo, A.; et al. Comparative study of biological activity of three commercial products of Sasa senanensis Rehder leaf extract. In Vivo 2012, 26, 259–264. [Google Scholar]
  4. Pang, X.; Wang, Y.; Wu, J.; Zhou, Z.; Xu, T.; Jin, L.; Yu, Y.; Li, Z.; Gobin, R.; Xue, C.; et al. Yunnan Baiyao Conditioned Medium Promotes the Odonto/Osteogenic Capacity of Stem Cells from Apical Papilla via Nuclear Factor Kappa B Signaling Pathway. Biomed. Res. Int. 2019, 2019, 9327386. [Google Scholar] [CrossRef]
  5. Kim, H.; Kim, C.; Kim, D.U.; Chung, H.C.; Hwang, J.K. Inhibitory Effects of Boesenbergia pandurata on Age-Related Periodontal Inflammation and Alveolar Bone Loss in Fischer 344 Rats. J. Microbiol. Biotechnol. 2018, 28, 357–366. [Google Scholar] [CrossRef] [PubMed]
  6. Kagermeier-Callaway, A.S.; Bredick, J.; Willershausen, B. Effect of three mouthrinses, containing amine/stannous fluoride, herbal extracts or Emser salt on the growth of oral bacteria—An in vitro study. Eur. J. Med. Res. 2000, 5, 523–529. [Google Scholar] [PubMed]
  7. Matsuta, T.; Sakagami, H.; Tanaka, S.; Machino, M.; Tomomura, M.; Tomomura, A.; Yasui, T.; Itoh, K.; Sugiura, T.; Kitajima, M.; et al. Pilot clinical study of Sasa senanensis Rehder leaf extract treatment on lichenoid dysplasia. In Vivo 2012, 26, 957–962. [Google Scholar] [PubMed]
  8. Sakagami, H. Biological activities and possible dental application of three major groups of polyphenols. J. Pharmacol. Sci. 2014, 126, 92–106. [Google Scholar] [CrossRef][Green Version]
  9. Ono, M.; Kantoh, K.; Ueki, J.; Shimada, A.; Wakabayashi, H.; Matsuta, T.; Sakagami, H.; Kumada, H.; Hamada, N.; Kitajima, M.; et al. Quest for anti-inflammatory substances using IL-1β-stimulated gingival fibroblasts. In Vivo 2011, 25, 763–768. [Google Scholar]
  10. Fukuchi, K.; Sakagami, H.; Sugita, Y.; Takao, K.; Asai, D.; Terakubo, S.; Takemura, H.; Ohno, H.; Horiuchi, M.; Suguro, M.; et al. Quantification of the Ability of Natural Products to Prevent Herpes Virus Infection. Medicines 2020, 7, 64. [Google Scholar] [CrossRef] [PubMed]
  11. Sakagami, H.; Zhou, L.; Kawano, M.; Thet, M.M.; Tanaka, S.; Machino, M.; Amano, S.; Kuroshita, R.; Watanabe, S.; Chu, Q.; et al. Multiple biological complex of alkaline extract of the leaves of Sasa senanensis Rehder. In Vivo 2010, 24, 735–743. [Google Scholar]
  12. Huang, J.Q.; Qi, R.T.; Pang, M.R.; Liu, C.; Li, G.Y.; Zhang, Y. Isolation, chemical characterization, and immunomodulatory activity of naturally acetylated hemicelluloses from bamboo shavings. J. Zhejiang Univ. Sci. B 2017, 18, 138–151. [Google Scholar] [CrossRef] [PubMed][Green Version]
  13. Sakagami, H.; Matsuta, T.; Satoh, K.; Ohtsuki, S.; Shimada, C.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Morita, Y.; Ohkubo, A.; et al. Biological activity of SE-10, granulated powder of Sasa senanensis Rehder leaf extract. In Vivo 2012, 26, 411–418. [Google Scholar] [PubMed]
  14. Kantoh, K.; Ono, M.; Nakamura, Y.; Nakamura, Y.; Hashimoto, K.; Sakagami, H.; Wakabayashi, H. Hormetic and anti-radiation effects of tropolone-related compounds. In Vivo 2010, 24, 843–851. [Google Scholar] [PubMed]
  15. Garcia-Contreras, R.; Sugimoto, M.; Umemura, N.; Kaneko, M.; Hatakeyama, Y.; Soga, T.; Tomita, M.; Scougall-Vilchis, R.J.; Contreras-Bulnes, R.; Nakajima, H.; et al. Alteration of metabolomic profiles by titanium dioxide nanoparticles in human gingivitis model. Biomaterials 2015, 57, 33–40. [Google Scholar] [CrossRef] [PubMed]
  16. Sugimoto, M.; Wong, D.T.; Hirayama, A.; Soga, T.; Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010, 6, 78–95. [Google Scholar] [CrossRef][Green Version]
  17. Sakagami, H.; Shi, H.; Bandow, K.; Tomomura, M.; Tomomura, A.; Horiuchi, M.; Fujisawa, T.; Oizumi, T. Search of Neuroprotective Polyphenols Using the “Overlay” Isolation Method. Molecules 2018, 23, 1840. [Google Scholar] [CrossRef][Green Version]
  18. Morrison, I.M. Structural invesiigations on the lignin-carbohydrate complexes of Lolium perenne. Biochem. J. 1974, 139, 197–204. [Google Scholar] [CrossRef][Green Version]
  19. Allerdings, E.; Ralph, J.; Steinhart, H.; Bunzel, M. Isolation and structural identification of complex feruloylated heteroxylan side-chains from maize bran. Phytochemistry 2006, 67, 1276–1286. [Google Scholar] [CrossRef]
  20. Wang, Y.; Kang, W.; Shang, L.; Song, A.; Ge, S. N-WASP knockdown upregulates inflammatory cytokines expression in human gingival fibroblasts. Arch. Oral. Biol. 2020, 110, 104605. [Google Scholar] [CrossRef]
  21. Ara, T.; Sogawa, N. Effects of shinbuto and ninjinto on prostaglandin E(2) production in lipopolysaccharide-treated human gingival fibroblasts. PeerJ 2017, 5, e4120. [Google Scholar] [CrossRef] [PubMed][Green Version]
  22. Kato, T.; Segami, N.; Sakagami, H. Anti-inflammatory Activity of Hangeshashinto in IL-1β-stimulated Gingival and Periodontal Ligament Fibroblasts. In Vivo 2016, 30, 257–263. [Google Scholar] [PubMed]
  23. Suzuki, S.; Kodera, Y.; Saito, T.; Fujimoto, K.; Momozono, A.; Hayashi, A.; Kamata, Y.; Shichiri, M. Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress. Sci. Rep. 2016, 6, 38299. [Google Scholar] [CrossRef][Green Version]
  24. Holte, K.B.; Svanteson, M.; Hanssen, K.F.; Sveen, K.A.; Seljeflot, I.; Solheim, S.; Sell, D.R.; Monnier, V.M.; Berg, T.J. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study. PLoS ONE 2020, 15, e0233174. [Google Scholar] [CrossRef] [PubMed]
  25. Aledo, J.C.; Aledo, P. Susceptibility of Protein Methionine Oxidation in Response to Hydrogen Peroxide Treatment-Ex Vivo Versus In Vitro: A Computational Insight. Antioxidants 2020, 9, 987. [Google Scholar] [CrossRef]
  26. Sourdon, J.; Keceli, G.; Lindsey, M.L.; Paolocci, N. Death of an antioxidant brings heart failure with preserved ejection fraction to life: 5-oxoproline and post-ischaemic cardio-renal dysfunction. Cardiovasc. Res. 2018, 114, 1819–1821. [Google Scholar] [CrossRef] [PubMed]
  27. Van der Pol, A.; Gil, A.; Tromp, J.; Silljé, H.H.W.; van Veldhuisen, D.J.; Voors, A.A.; Hoendermis, E.S.; Grote Beverborg, N.; Schouten, E.M.; de Boer, R.A.; et al. OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: A murine model for heart failure with a preserved ejection fraction. Cardiovasc. Res. 2018, 114, 1871–1882. [Google Scholar] [CrossRef]
  28. Bachhawat, A.K.; Yadav, S.; Jainarayanan, A.K.; Dubey, P. Heart failure and the glutathione cycle: An integrated view. Biochem. J. 2020, 477, 3123–3130. [Google Scholar] [CrossRef] [PubMed]
  29. Gut, P.; Verdin, E. The nexus of chromatin regulation and intermediary metabolism. Nature 2013, 502, 489–498. [Google Scholar] [CrossRef] [PubMed]
  30. Zamaraeva, M.V.; Sabirov, R.Z.; Maeno, E.; Ando-Akatsuka, Y.; Bessonova, S.V.; Okada, Y. Cells die with increased cytosolic ATP during apoptosis: A bioluminescence study with intracellular luciferase. Cell Death Differ. 2005, 12, 1390–1397. [Google Scholar] [CrossRef]
  31. Basso, F.G.; Pansani, T.N.; Turrioni, A.P.; Soares, D.G.; de Souza Costa, C.A.; Hebling, J. Tumor Necrosis Factor-α and Interleukin (IL)-1β, IL-6, and IL-8 Impair In Vitro Migration and Induce Apoptosis of Gingival Fibroblasts and Epithelial Cells, Delaying Wound Healing. J. Periodontol. 2016, 87, 990–996. [Google Scholar] [CrossRef] [PubMed]
  32. Vardar-Sengul, S.; Arora, S.; Baylas, H.; Mercola, D. Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation. J. Periodontol. 2009, 80, 833–849. [Google Scholar] [CrossRef]
  33. Song, H.K.; Noh, E.M.; Kim, J.M.; You, Y.O.; Kwon, K.B.; Lee, Y.R. Reversine inhibits MMP-3, IL-6 and IL-8 expression through suppression of ROS and JNK/AP-1 activation in interleukin-1β-stimulated human gingival fibroblasts. Arch. Oral Biol. 2019, 108, 104530. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, S.; Ahn, S.H.; Lee, J.S.; Song, J.E.; Cho, S.H.; Jung, S.; Kim, S.K.; Kim, S.H.; Lee, K.P.; Kwon, K.S.; et al. Differential Matrix Metalloprotease (MMP) Expression Profiles Found in Aged Gingiva. PLoS ONE 2016, 11, e0158777. [Google Scholar] [CrossRef][Green Version]
  35. Hosokawa, Y.; Hosokawa, I.; Ozaki, K.; Nakae, H.; Matsuo, T. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Clin. Exp. Immunol. 2006, 146, 540–549. [Google Scholar] [CrossRef] [PubMed]
  36. Hosokawa, Y.; Hosokawa, I.; Ozaki, K.; Nakae, H.; Matsuo, T. Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts. J. Cell Biochem. 2010, 111, 40–48. [Google Scholar] [CrossRef]
  37. Sakagami, H.; Amano, S.; Kikuchi, H.; Nakamura, Y.; Kuroshita, R.; Watanabe, S.; Satoh, K.; Hasegawa, H.; Nomura, A.; Kanamoto, T.; et al. Antiviral, antibacterial and vitamin C-synergized radical-scavenging activity of Sasa senanensis Rehder extract. In Vivo 2008, 22, 471–476. [Google Scholar]
  38. Sakagami, H.; Fukuchi, K.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Natori, T.; Suguro-Kitajima, M.; Oizumi, H.; Yasui, T.; Oizumi, T. Synergism of Alkaline Extract of the Leaves of Sasa senanensis Rehder and Antiviral Agents. In Vivo 2016, 30, 421–426. [Google Scholar]
  39. Sakagami, H.; Kushida, T.; Oizumi, T.; Nakashima, H.; Makino, T. Distribution of lignin-carbohydrate complex in plant kingdom and its functionality as alternative medicine. Pharmacol. Ther. 2010, 128, 91–105. [Google Scholar] [CrossRef]
  40. Sakagami, H.; Nagata, K.; Ishihama, A.; Oh-hara, T.; Kawazoe, Y. Anti-influenza virus activity of synthetically polymerized phenylpropenoids. Biochem. Biophys. Res. Commun. 1990, 172, 1267–1272. [Google Scholar] [CrossRef]
  41. Nakashima, H.; Murakami, T.; Yamamoto, N.; Naoe, T.; Kawazoe, Y.; Konno, K.; Sakagami, H. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins. Chem. Pharm. Bull. 1992, 40, 2102–2105. [Google Scholar] [CrossRef] [PubMed][Green Version]
  42. Harada, H.; Sakagami, H.; Nagata, K.; Oh-hara, T.; Kawazoe, Y.; Ishihama, A.; Hata, N.; Misawa, Y.; Terada, H.; Konno, K. Possible involvement of lignin structure in anti-influenza virus activity. Antivir. Res. 1991, 15, 41–49. [Google Scholar] [CrossRef]
  43. Fukuchi, K.; Sakagami, H.; Ikeda, M.; Kawazoe, Y.; Oh-Hara, T.; Konno, K.; Ichikawa, S.; Hata, N.; Kondo, H.; Nonoyama, M. Inhibition of herpes simplex virus infection by pine cone antitumor substances. Anticancer Res. 1989, 9, 313–317. [Google Scholar] [PubMed]
  44. Fukuchi, K.; Sakagami, H.; Okuda, T.; Hatano, T.; Tanuma, S.; Kitajima, K.; Inoue, Y.; Inoue, S.; Ichikawa, S.; Nonoyama, M.; et al. Inhibition of herpes simplex virus infection by tannins and related compounds. Antivir. Res. 1989, 11, 285–297. [Google Scholar] [CrossRef]
  45. Sakagami, H.; Satoh, K.; Ida, Y.; Koyama, N.; Premanathan, M.; Arakaki, R.; Nakashima, H.; Hatano, T.; Okuda, T.; Yoshida, T. Induction of apoptosis and anti-HIV activity by tannin- and lignin-related substances. Basic Life Sci. 1999, 66, 595–611. [Google Scholar] [CrossRef] [PubMed]
  46. Fukai, T.; Sakagami, H.; Toguchi, M.; Takayama, F.; Iwakura, I.; Atsumi, T.; Ueha, T.; Nakashima, H.; Nomura, T. Cytotoxic activity of low molecular weight polyphenols against human oral tumor cell lines. Anticancer Res. 2000, 20, 2525–2536. [Google Scholar]
Jcm 10 02100 g001 550
Figure 1. Kinetics of inhibition of IL-1β-induced human gingival fibroblast PGE2 production by SE. (A) Dose–response: IL-β stimulated the production of PGE2 in HGF, HPLF, but not in HPC. (B) Time-course of PGE2 production after IL-1β (3 mg/mL) addition. (C) SE did not interfere with the PGE2 measurement. (D) SE inhibited the IL-1β-stimulated PGE2 production more effectively when HGF cells were first treated by SE before IL-1β addition. (E) Prolonged pretreatment with IL-1β (3 mg/mL) reduced the inhibitory effect of SE to a greater extent.
Figure 1. Kinetics of inhibition of IL-1β-induced human gingival fibroblast PGE2 production by SE. (A) Dose–response: IL-β stimulated the production of PGE2 in HGF, HPLF, but not in HPC. (B) Time-course of PGE2 production after IL-1β (3 mg/mL) addition. (C) SE did not interfere with the PGE2 measurement. (D) SE inhibited the IL-1β-stimulated PGE2 production more effectively when HGF cells were first treated by SE before IL-1β addition. (E) Prolonged pretreatment with IL-1β (3 mg/mL) reduced the inhibitory effect of SE to a greater extent.
Jcm 10 02100 g001
Jcm 10 02100 g002 550
Figure 2. Metabolomic analysis of HGF cells incubated for 3 h without (control) (column 1) or with SE (2%) (column 2), IL-1β (3 ng/mL) (column 3) and SE (2%) + IL-1β (3 ng/mL) (column 4). The averaged concentrations of samples (n = 4) for each condition are visualized. To determine the color, the average concentration was calculated for each metabolite, and individual metabolite concentration was divided by the average. The metabolites of the cultured cell (A) were aligned by the clustering with Pearson Correlation, and the metabolites of the supernatant (B) were aligned according to the data in (A). The numbers of cells recovered per dish are 1.06 ± 0.086 × 106, 1.16 ± 0.068 × 106, 1.21 ± 0.12 × 106, and 1.12 ± 0.053 × 106, respectively. Blue, white, and red indicate fold changes of 0.8, 1, and 1.2, respectively, compared to the average of each metabolite. The gray indicates that the corresponding metabolite is not detected. The names of metabolites can be visible by 4-fold magnification with zooming. Original data are available in Supplemental Table S1.
Figure 2. Metabolomic analysis of HGF cells incubated for 3 h without (control) (column 1) or with SE (2%) (column 2), IL-1β (3 ng/mL) (column 3) and SE (2%) + IL-1β (3 ng/mL) (column 4). The averaged concentrations of samples (n = 4) for each condition are visualized. To determine the color, the average concentration was calculated for each metabolite, and individual metabolite concentration was divided by the average. The metabolites of the cultured cell (A) were aligned by the clustering with Pearson Correlation, and the metabolites of the supernatant (B) were aligned according to the data in (A). The numbers of cells recovered per dish are 1.06 ± 0.086 × 106, 1.16 ± 0.068 × 106, 1.21 ± 0.12 × 106, and 1.12 ± 0.053 × 106, respectively. Blue, white, and red indicate fold changes of 0.8, 1, and 1.2, respectively, compared to the average of each metabolite. The gray indicates that the corresponding metabolite is not detected. The names of metabolites can be visible by 4-fold magnification with zooming. Original data are available in Supplemental Table S1.
Jcm 10 02100 g002
Jcm 10 02100 g003 550
Figure 3. Flow chart of DNA array analysis.
Figure 3. Flow chart of DNA array analysis.
Jcm 10 02100 g003
Jcm 10 02100 g004 550
Figure 4. The expression intensity of each sample was expressed in a logarithmic scale using a line graph as a reference for control. In total, 16,405 spots with fluctuations of Log 2 (2) or more compared to the control were analyzed. Genes with higher mean expression intensity compared to the control are shown in red, and genes with lower mean expression intensity are shown in blue.
Figure 4. The expression intensity of each sample was expressed in a logarithmic scale using a line graph as a reference for control. In total, 16,405 spots with fluctuations of Log 2 (2) or more compared to the control were analyzed. Genes with higher mean expression intensity compared to the control are shown in red, and genes with lower mean expression intensity are shown in blue.
Jcm 10 02100 g004
Jcm 10 02100 g005 550
Figure 5. Enhanced mRNA expression of tumor necrosis factor superfamily, member 2 (TNFA), RAC serine/threonine-protein kinase (AKT), caspase 3 (CASP3), and CXC motif chemokine (CXCl13) on the TNF pathway by IL1-β.
Figure 5. Enhanced mRNA expression of tumor necrosis factor superfamily, member 2 (TNFA), RAC serine/threonine-protein kinase (AKT), caspase 3 (CASP3), and CXC motif chemokine (CXCl13) on the TNF pathway by IL1-β.
Jcm 10 02100 g005
Table
Table 1. Metabolites downregulated by IL-1β and reversed by SE.
Table 1. Metabolites downregulated by IL-1β and reversed by SE.
Metabolites (Amol/Cell)
Control(%)IL-1β(%)SE(%)SE + IL-1β(%)
Amino acids
Gly211,177100146,16869211,841100185,66788
Ala60,88810033,2725551,2518440,89867
Arg9902100646465823683707771
Asp26,44510017,4096619,4567417,65467
Asn15,19210086355711,97079971864
Gln337,154100197,77159283,38384241,16472
Glu287,270100258,70990239,06483255,67989
His13,30110074075610,62580804160
Ile35,81010022,5316332,0879025,84372
Leu37,50610022,6116033,7309026,28670
Lys24,97410015,9176420,3508117,36570
Met15,48910072744711,71776854855
Phe29,01510016,9435824,9548619,25266
Pro62,14810049,9048061,7879956,77391
Ser47,58710029,0616142,2198935,21574
Thr140,11710073,93153113,0948191,62265
Trp6312100344755600195441870
Tyr30,04910017,1775725,4658519,56465
Val29,76310019,5476628,2929522,76876
Total1,420,101100954,178621235,525861093,55271
Glutathiones
GSH41,74310045,31510940,3779736,92788
GSSG19,33410069053617,1098815,96583
Cys-GSH disulfide4611002763948532971
Total61,53810052,2488557,8809453,22186
Others
Met-sulfoxide2831001754131674297149
5-Oxoproline88061007801898281949507108
SAM+713100324454266044362
ATP/GTP utilization
ATP64,58110046,7787246,9067346,78772
ADP40741004734116345685372992
AMP4251005811363337842399
AMP/ATP0.00661000.01241880.00711080.0090137
ADP/ATP0.06311000.10121600.07371170.0797126
GTP14,95910012,7308513,8809314,10694
GDP74710086111571395776104
GMP16210019812312376165102
GMP/GTP0.01081000.01561440.0089820.0117109
GDP/GTP0.04991000.06761350.05141030.0550110
Each value is the mean of 4 determinations. SD values of each metabolite are available in Supplemental Table S2.
Table
Table 2. Metabolites downregulated by IL-1β and reversed by SE.
Table 2. Metabolites downregulated by IL-1β and reversed by SE.
Expression (2n-Fold Increase)
ControlSEIL-1βSE + IL-1β
Btk0.0000.0001.1080.000
calpain0.0000.0002.1390.000
calpain 130.0000.0002.1390.000
collagenase-IV0.0000.0003.2320.000
Lefty0.0000.0003.5210.000
Lefty20.0000.0003.5210.000
MMP0.0000.0003.2320.000
MMP-20.0000.0003.2320.000
Nbeta0.0000.0001.1210.000
NEXT0.0000.0001.1210.000
NICD0.0000.0001.1210.000
Notch0.0000.0001.1210.000
Notch20.0000.0001.1210.000
NRPTP0.0000.0002.0170.000
PKC0.0000.0001.6760.000
PKCd0.0000.0001.6760.000
Shp10.0000.0002.0170.000
TGFb0.0000.0003.5210.000
TLR0.0000.0002.4780.000
TLR90.0000.0002.4780.000
TNF0.0000.0001.4390.255
TNFa0.0000.0001.4390.255
AKT0.000−0.1892.320−0.309
AKT20.000−0.1892.320−0.309
caspase0.000−0.7051.072−0.151
caspase-30.000−0.7051.072−0.151
CXCL30.0000.1108.8267.756
CXCL50.000−0.3013.0381.990
CXCL100.0000.0003.2542.252
CCL70.0000.0004.1483.141
Data for a total of 366 gene expressions are available in Supplementary Table S3.
Table
Table 3. Summary of anti-inflammatory action of SE against IL-1β-treated HGF cells.
Table 3. Summary of anti-inflammatory action of SE against IL-1β-treated HGF cells.
+ IL-1β +SE+ IL-1β
Metabolomic analysis
19 Amino acids (except Cys and Glu)↓→↑
Total glutathione (GSH, GSSG, Cys-GSH disulfide)↓→↑
Met-sulfoxide↓→↑
5-Oxoproline↓→↑
SAM↓→↑
DNA array analysis
AKT (Cell survival)↑→↓
CASP3 (Apoptosis)↑→↓
CXCL3 (Leukocyte recruitment)↑→↓
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sakagami, H.; Nakatani, S.; Enomoto, A.; Ota, S.; Kaneko, M.; Sugimoto, M.; Horiuchi, M.; Toeda, K.; Oizumi, T. Multi-Omics Analysis of Anti-Inflammatory Action of Alkaline Extract of the Leaves of Sasa sp. J. Clin. Med. 2021, 10, 2100. https://doi.org/10.3390/jcm10102100

AMA Style

Sakagami H, Nakatani S, Enomoto A, Ota S, Kaneko M, Sugimoto M, Horiuchi M, Toeda K, Oizumi T. Multi-Omics Analysis of Anti-Inflammatory Action of Alkaline Extract of the Leaves of Sasa sp. Journal of Clinical Medicine. 2021; 10(10):2100. https://doi.org/10.3390/jcm10102100

Chicago/Turabian Style

Sakagami, Hiroshi, Sachie Nakatani, Ayame Enomoto, Sana Ota, Miku Kaneko, Masahiro Sugimoto, Misaki Horiuchi, Kazuki Toeda, and Takaaki Oizumi. 2021. "Multi-Omics Analysis of Anti-Inflammatory Action of Alkaline Extract of the Leaves of Sasa sp." Journal of Clinical Medicine 10, no. 10: 2100. https://doi.org/10.3390/jcm10102100

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop